A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function

Clinical trial NCT05940402 · COMPLETED

Trial details

NCT number: NCT05940402
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2023-07-24
Primary completion: 2024-12-19
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.